Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 18/01/2011
PIL Macugen 0.3 mg solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 07/04/2009 and displayed until 18/01/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 15/05/2008 and displayed until 07/04/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/01/2008 and displayed until 15/05/2008
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
  • Change to side-effects
Updated on 14/05/2007 and displayed until 25/01/2008
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Addition of Marketing Authorisation Holder
Updated on 21/12/2006 and displayed until 14/05/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to name of manufacturer
Updated on 22/05/2006 and displayed until 21/12/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   pegaptanib sodium